Anti-Lck-interacting molecule antibody

Anti-Lck-interacting molecule antibody

Catalog Number:
IGA1028124STJ
Mfr. No.:
STJ16100293
Price:
$812
  • Size:
    0.1 mg
    Quantity:
    Add to Cart:
      • Overview
        • Reacts with the cytoplasmic domain of LIME, a 30 kDa Lck-interacting transmembraneadaptor expressed by T cells. LIME (Lck-interacting molecule) is a raft-associated adaptor proteininvolved in regulation of T cell activation by coreceptors. LIME becomes tyrosine phosphorylated aftercross-linking of the CD4 or CD8 coreceptors. Phospho-LIME associates with the Src family kinase Lckand its negative regulator, Csk. Ectopic expression of LIME in Jurkat T cells results in an increase of Cskin lipid rafts, increased phosphorylation of Lck and higher Ca2+ response to CD3 stimulation.Immunogen: COOH-terminal peptide comprising residues 281-296 of the human LIME conjugated tokeyhole limpet hemocyanin.

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          mouse
          Antibody Type
          monoclonal
          Isotype
          IgG2a
          Reactivity
          human
          Clone
          LIME-10
          Immunogen
          COOH-terminal peptide comprising residues 281-296 of the human LIME conjugated to keyhole limpet hemocyanin
          Conjugate
          Unconjugated
          Formulation
          100 µg purified antibody in Phosphate buffered saline, containing 15 mM sodiumazide.
          Storage
          Store antibody at 2-8°C until expiry date. Minimise freeze-thaw cycles.
          Concentration
          1 mg/ml
          Regulatory Status
          RUO
          Antigen
          Lck-Interacting Transmembrane Adapter 1; Lck-Interacting Membrane Protein; Lck-Interacting Molecule (Gene ID:54923; UniProt:Q9H400)

          * For research use only

      • Applications
        • Application
          IHC (paraffin); WB

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.